B K Smruti
Overview
Explore the profile of B K Smruti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Im S, Gennari A, Park Y, Kim J, Jiang Z, Gupta S, et al.
ESMO Open
. 2023 May;
8(3):101541.
PMID: 37178669
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer (MBC) was published...
2.
Yoshino T, Argiles G, Oki E, Martinelli E, Taniguchi H, Arnold D, et al.
Ann Oncol
. 2021 Aug;
32(12):1496-1510.
PMID: 34411693
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of localised colon cancer was published in 2020. It...
3.
Moreker M, Dudani A, Sharma T, Patel K, Smruti B
Indian J Ophthalmol
. 2020 Aug;
68(9):2054-2056.
PMID: 32823479
An immunocompetent, 25-year-old gentleman with bilateral chronic uveitis presented to various uveitis clinics at different points of time with documented typical clinical features of Toxoplasma Chorioretinitis (Headlight in fog appearance),...
4.
Malhotra H, Kowtal P, Mehra N, Pramank R, Sarin R, Rajkumar T, et al.
JCO Glob Oncol
. 2020 Jul;
6:991-1008.
PMID: 32628584
Purpose: Hereditary breast and ovarian cancer (HBOC) syndrome is primarily characterized by mutations in the genes. There are several barriers to the implementation of genetic testing and counseling in India...
5.
Park Y, Senkus-Konefka E, Im S, Pentheroudakis G, Saji S, Gupta S, et al.
Ann Oncol
. 2020 Feb;
31(4):451-469.
PMID: 32081575
In view of the planned new edition of the most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of...
6.
Talapatra K, Majumder D, Chadha P, Shaju P, Goyle S, Smruti B, et al.
Indian J Cancer
. 2019 Jan;
55(2):170-175.
PMID: 30604731
Introduction: Stereotactic body radiotherapy (SBRT) has emerged as an important modality in malignant lung tumor treatment both in early localized primary and oligometastatic setting. This study aims to present the...
7.
Gupta S, Singh M, Vora A, Babu G, Walia M, Nautial V, et al.
South Asian J Cancer
. 2018 May;
7(2):142-145.
PMID: 29721482
Optimization of adjuvant systemic therapy in women with early-stage hormone receptor-positive breast cancer includes the consideration of chemotherapy and duration of hormone therapy. Adjuvant hormonal therapy significantly improves long-term survival...
8.
Rangarao R, Smruti B, Singh K, Batra S, Choudhary R, Gupta A, et al.
South Asian J Cancer
. 2018 May;
7(2):127-131.
PMID: 29721479
Patients with breast cancer along with metastatic estrogen and progesterone receptor (ER/PR)- and human epidermal growth factor receptor 2 (HER2)-negative tumors are referred to as having metastatic triple-negative breast cancer...
9.
Babu G, Goel A, Agarwal S, Gupta S, Kumar P, Smruti B, et al.
South Asian J Cancer
. 2018 May;
7(2):123-126.
PMID: 29721478
Breast cancer is a leading cause of death among women, and its incidence increases with age. Currently the treatment of breast cancer in older patients is almost identical to their...
10.
Singh J, Thota N, Singh S, Padhi S, Mohan P, Deshwal S, et al.
Breast Cancer Res Treat
. 2018 Feb;
170(1):189-196.
PMID: 29470806
Purpose: Breast and/or ovarian cancers are among the most common cancers in women across the world. In the Indian population, the healthcare burden of breast and/or ovarian cancers has been...